Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1991-08-14 to 1991-08-29
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1992
Report date:
1992

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of inspection 1990-05-14
Test type:
acute toxic class method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Benzoic acid, 2-hydroxy-, mono-C14-18-alkyl derivs., calcium salts (2:1)
EC Number:
931-276-9
Cas Number:
114959-46-5
Molecular formula:
See information in Section 1.2.
IUPAC Name:
Benzoic acid, 2-hydroxy-, mono-C14-18-alkyl derivs., calcium salts (2:1)
Details on test material:
- Name of test material (as cited in study report): [CAS Number 114959-46-5]
- Physical state: Clear brown viscous liquid
- Lot/batch No.: 191 (Stanlow); DSP4767/91
- Toxicology reference number: ST91/247
- Stability under test conditions: Stable for the duration of the study under the test conditions employed
- Storage condition of test material: In the dark at ambient temperature under nitrogen
- Date received: 08 August 1991

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River UK Ltd
- Age at study initiation: 8-9 weeks
- Weight at study initiation: 195-219 g (males); 137-155 g (females)
- Fasting period before study: Overnight
- Housing: Single sex groups of up to 5 rats to a cage during quarantine; Single sex groups of up to 3 rats to a cage for at least five days prior to dosing in cages with stainless steel wire-mesh walls floors and tops. Each cage measured 33 cm x 22 cm x 16 cm. Paper-lined trays for excreta were placed beneath each cage and changed three times weekly.
- Diet (e.g. ad libitum): Pelleted diet (LAD 1, Special Diets Services Ltd) ad libitum
- Water (e.g. ad libitum): Water from the public supply ad libitum
- Acclimation period: Minimum of four days quarantine in non-barried animal room with access restricted to essential personnel plus five days acclimation prior to dosing

ENVIRONMENTAL CONDITIONS
- Temperature: 19-23 degrees Centigrade with no excursions considered to have influenced the experimental outcome
- Humidity: 30-70 % with no excursions considered to have influenced the experimental outcome
- Photoperiod: 12 hour day and 12 hour night provided by automatically controlled fluorescent lighting

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
Fasted animals were weighed and given a single dose of test material by gavage using a ball pointed cannula and syringe. The animals were permitted food ad libitum approximately 2.5 hours after dosing on Day 1.
Doses:
Single doseof 5000 mg/kg administered as a dose volume of 4.76 mL/kg
No. of animals per sex per dose:
5 males and 5 females
Control animals:
no
Details on study design:
Animals assigned to the study were identified by cage labels displaying the animal numbers, experiment number, sex and test material and by ear-notches denoting the animal number.

A detailed clinical examination was made seven times daily on the day of dosing (Day 1) and twice daily thereafter for the remainder of the 14 day observation period. The initial (Day 1), Day 8 and Day 15 bodyweights were recorded and changes in bodyweight calculated.

All animals were subject to necropsy. Animals were killed by an intraperitoneal injection of sodium pentobarbitone on Day 15. External surfaces and orifices were checked and the cranial, thoracic and abdominal cavities and viscera were examined. Any gross pathological changes were recorded.
Statistics:
No data

Results and discussion

Preliminary study:
No data
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Mortality:
No animals died
Clinical signs:
other: All rats developed a hunched posture, diarrhoea and an unkempt appearance within 2.5 hours of dosing. Anogenital fur staining (yellow) also affected all rats by Day 2. Other clinical signs were limited to isolated cases of piloerection. Recovery, as judge
Gross pathology:
No macroscopic changes were apparent during necropsy of the rats on Day 15.
Other findings:
No data

Any other information on results incl. tables

Table 1 - Mortality following acute oral administration of test material to rats (attached)

Table 2 - Bodyweight and bodyweight change following acute oral administration of test material to rats (attached)

Table 3 - Clinical observations following acute oral administration of test material to rats (attached)

Table 4 - Necropsy findings in rats following a single dose of test material (attached)

Applicant's summary and conclusion

Conclusions:
The acute oral LD50 of the test material in fasted rats was greater than 5000 mg/kg.